HCPCS Code Details - J7311

HCPCS Level II Code
Drugs administered other than oral method, chemotherapy drugs
HCPCS Code J7311
Description

Long description:
Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg

Short description:
Inj., retisert, 0.01 mg

HCPCS Modifier1
HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code C - Carrier judgment
ASC payment group code Effective Jan 01, 2008 - This procedure is approved to be performed in an ambulatory surgical center.
BETOS2 code O1E - Other drugs
HCPCS Action code N - No maintenance for this code
Type of service Q - Vision items or services
Effective date Effective Oct 01, 2019
Date added Added Jan 01, 2007
HCPCS Coding Procedures

HCPCS Modifiers

In HCPCS Level II, modifiers are composed of two alpha or alphanumeric characters.

Example: E0260-NU - Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress
NU” identifies the hospital bed as new equipment

ASP Drug pricing - J7311

Effective Code Dosage Payment
Limit
Vaccine AWP % Vaccine Limit Infusion AWP % DME infusion limit Blood AWP % Blood limit Clotting factor Note
January 1, 2024 - March 31, 2024 0.01 MG 299.05 - - - - - -
October 1, 2023 - December 31, 2023 0.01 MG 341.4 20% - - - - -
Jul 1, 2023 - Sep 30, 2023 0.01 MG 322.381 20% - - - - -
April 1, 2023 - June 30, 2023 0.01 MG 337.684 20% - - - - -
0.01 MG 336.018 - - - - - -

See also

  • HCPCS J7310 · Ganciclovir, 4.5 mg, long-acting implant

  • HCPCS J7313 · Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg

  • HCPCS J7314 · Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg

  • HCPCS J7312 · Injection, dexamethasone, intravitreal implant, 0.1 mg


1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”